TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	4C6H11NO.BF4.Cu
Molecular Weight	602.981
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE

Structure Search

SMILES

[Cu+].F[B-](F)(F)F.COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-]

InChI

InChIKey=WJRFSUVOHUMYAO-UHFFFAOYSA-N

InChI=1S/4C6H11NO.BF4.Cu/c4*1-6(2,8-4)5-7-3;2-1(3,4)5;/h4*5H2,1-2,4H3;;/q;;;;-1;+1

HIDE SMILES / InChI

Molecular Formula	BF4
Molecular Weight	86.805
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Cu
Molecular Weight	63.546
Charge	1
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C6H11NO
Molecular Weight	113.1576
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Coronary artery disease 48 Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4110d0f4-3bcf-4688-a39f-42a81064c796	Diagnostic		Approved 8583	TECHNETIUM TC 99M SESTAMIBI Approved Use Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Launch Date 1990
Breast disease 2 Sources: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=4110d0f4-3bcf-4688-a39f-42a81064c796	Diagnostic		Approved 8583	TECHNETIUM TC 99M SESTAMIBI Approved Use Technetium Tc 99m Sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. Launch Date 1990

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:46:32 GMT 2025` Edited by `admin` on `Mon Mar 31 17:46:32 GMT 2025`
Record UNII	N6OU7HJ70P
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TETRAKIS (2-METHOXY ISOBUTYL ISONITRILE) COPPER (I) TETRAFLUOROBORATE

Preferred Name

English

TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE

Common Name

English

TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE [II]

Common Name

English

PROPANE, 1-ISOCYANO-2-METHOXY-2-METHYL-, COPPER COMPLEX

Common Name

English

Cardioite [WHO-DD]

Common Name

English

CARDIO-SPECT

Brand Name

English

CARDIOSPECT

Brand Name

English

COPPER(1+), TETRAKIS(1-(ISOCYANO-.KAPPA.C)-2-METHOXY-2-METHYLPROPANE)-, (T-4)-, TETRAFLUOROBORATE(1-)

Common Name

English

TETRAKIS(2-METHOXYISOBUTYLISONITRIL)COPPER (I) TETRAFLUOROBORATE

Common Name

English

TETRAKIS(1-ISOCYANO-2-METHOXY-2-METHYL-PROPANE)-COPPER(I) TETRAFLUOROBORATE

Common Name

English

CARDIOITE

Brand Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1937